例文
- In fresh ( rather than " in vitro " fertilization, final oocyte maturation triggering with GnRH agonist instead of hCG decreases the risk of ovarian hyperstimulation syndrome but decreases live birth rate.
- Using a GnRH agonist instead of hCG for inducing final oocyte maturation and / or release results in an elimination of the risk of ovarian hyperstimulation syndrome, but a slight decrease of the delivery rate of approximately 6 %.